# Valeo Pharma Inc. (VPHIF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VPHIF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 41.03M | $ -23.31M | $ -1.73M | $ 70.08M | $ -63.03M |
| 2023 | $ 55.94M | $ -28.85M | $ -22.05M | $ 65.17M | $ -40.34M |
| 2022 | $ 29.77M | $ -27.62M | $ -43.34M | $ 61.44M | $ -17.85M |
| 2021 | $ 15.46M | $ -16.23M | $ -18.11M | $ 7.67M | $ 2.05M |
| 2020 | $ 8.93M | $ -5.69M | $ -8.01M | $ 3.26M | $ 3.07M |
| 2019 | $ 7.96M | $ -4.56M | $ -3.92M | $ 1.00M | $ -22.0K |
| 2018 | $ 5.39M | $ -3.00M | $ -2.07M | $ 2.41M | $ -1.37M |
| 2017 | $ 758.6K | $ -2.12M | $ 63.6K | $ 4.44M | $ -2.60M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.11 |
| Liabilities / Eq | -1.51 |
| Current Ratio | 0.27 |

## Other views

- [Metrics](https://sponda.capital/en/VPHIF.md)
- [Charts](https://sponda.capital/en/VPHIF/charts.md)
- [Compare](https://sponda.capital/en/VPHIF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.
